Long-term outcomes of microwave ablation for secondary hyperparathyroidism in maintenance hemodialysis patients

Ther Apher Dial. 2021 Dec;25(6):926-930. doi: 10.1111/1744-9987.13640. Epub 2021 Apr 7.

Abstract

Microwave ablation has been increasingly used to secondary hyperparathyroidism (SHPT) in patients with maintenance hemodialysis. However, the current data are inconclusive. This study was to assess the long-term outcomes of microwave ablation on SHPT. We enrolled 53 SHPT patients who underwent microwave ablation. Primary outcome measures were the rate of achieving recommended goal for iPTH and the events of all-cause death during the follow-up period. Survival analysis was performed to assess the long-term prognosis. During follow-up period of 42.4 ± 15.6 months (range, 12-70 months), there were 12 all-cause deaths, and the cumulative proportion surviving was 0.74. The rates of achieving the recommended goal for iPTH were 62.3% at 1 month, 57.7% at 6 months, 51.0% at 12 months, 62.5% at 24 months, and 68.8% at 36 months, respectively. Microwave ablation produces a lasting resolution of secondary hyperparathyroidism in about 60% of patients with maintenance hemodialysis. The characteristics of patients suitable for microwave ablation should be clarified in the future.

Keywords: long-term outcome; maintenance hemodialysis; microwave ablation; secondary hyperparathyroidism.

MeSH terms

  • Ablation Techniques / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperparathyroidism, Secondary / etiology*
  • Hyperparathyroidism, Secondary / surgery*
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / therapy*
  • Male
  • Microwaves
  • Middle Aged
  • Renal Dialysis / methods*
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome